Abstract
Previous reports from the PANDA III trial had proven that the BuMA (SinoMed, Tianjin, China) biodegradable polymer (BP) sirolimus-eluting stents (SES), with faster drug eluting rate and polymer absorption kinetics, was non-inferior to the Excel (JW Medical, Weihai, China) SES in an all-comer
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
